Hellmann MD, et al. Efficacy/Safety of Entinostat (ENT) and Pembrolizumab (PEMBRO) in NSCLC Patients Previously Treated with Anti-PD-(L)1 Therapy. IASLC 2018, abstract OA05.01.
Cytosponge-TFF3 detecteert barrettslokdarm in de eerste lijn
jan 2021 | Endoscopie, Maag-darm-leveroncologie